Association of anti-HMGCR antibodies of the IgM isotype with refractory immune-mediated necrotizing myopathy
Arthritis Research & Therapy · 2024
DOI: 10.1186/s13075-024-03387-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis Research & Therapy, 2024. Verfasst von Hongxia Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Key Lab of Myositis, China-Japan Friendship Hospital, 2 Yinghua Road, Chaoyang District, Beijing, China. Hauptthemen laut MEDLINE: Immunoglobulin M, Autoantibodies, Hydroxymethylglutaryl CoA Reductases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National High Level Hospital Clinical Research Funding, Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
OBJECTIVE: Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) autoantibodies are one of the myositis-specific antibodies which is associated with immune-mediated necrotizing myopathy (IMNM). However, the relationship between anti-HMGCR isotypes and prognosis has not yet been fully investigated. This study was conducted to gain insight into the association between anti-HMGCR isotypes and clinical, and prognosis in IMNM patients who were positive for anti-HMGCR antibodies. METHODS: Levels of anti-HMGCR isotypes (IgG, IgA and IgM) were assessed by enzyme-linked immunosorbent assay (ELISA) in 123 consecutive serum samples obtained from 71 patients who were positive for anti-HMGCR IgG at baseline. Disease activity was assessed by manual muscle testing (MMT) 8, Physician's Global Assessment (PGA) visual analog scale (VAS), and muscle VAS. RESULTS: Baseline anti-HMGCR IgG levels were correlated with PGA VAS (r = 0.24; p = 0.04), muscle VAS (r = 0.32; p < 0.01), and MMT8(r=-0.24; p = 0.04), and baseline anti-HMGCR IgM levels were positively correlated with PGA VAS (r = 0.27, p = 0.02), muscle VAS (r = 0.24, p = 0.04). Anti-HMGCR IgM positive patients had a lower age of onset [29(25,46) vs. 51(33,65), p = 0.006], and a higher proportion of neck weakness (63.5% vs. 34.6%, p = 0.031) compared with anti-HMGCR IgM negative patients. Longitudinal analysis showed that the changes in anti-HMGCR IgG levels were correlated with the changes in the PGA VAS (β = 3.830; p < 0.0001), muscle VAS (β = 2.893; p < 0.0001), MMT8 (β=-19.368; p < 0.0001), and creatine kinase (CK) levels (β = 3900.05, p < 0.0001). Anti-HMGCR IgM levels were weakly correlated with anti-HMGCR IgA levels at baseline (r = 0.33, p < 0.01), and the variations in anti-HMGCR IgA levels were correlated with the changes in anti-HMGCR IgM levels during follow-up (β = 0.885; p < 0.0001). There were more patients with anti-HMGCR IgM who showed a refractory course than those who were with anti-HMGCR IgM negative (polycyclic course: 40% vs. 25%; chronic continuous course: 46.7% vs. 20.5%, p = 0.018). CONCLUSION: In anti-HMGCR IgG-positive IMNM patients, the levels of anti-HMGCR IgG are associated with disease activity, and anti-HMGCR IgM is associated with refractory outcome and poor prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Key Lab of Myositis, China-Japan Friendship Hospital, 2 Yinghua Road, Chaoyang District, Beijing, China.
- Department of Clinical Laboratory, Peking University First Hospital, Beijing, China.
- Department of Rheumatology, Key Lab of Myositis, China-Japan Friendship Hospital, 2 Yinghua Road, Chaoyang District, Beijing, China. luxin_n@163.com.
Förderung
- the National High Level Hospital Clinical Research Funding
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Yang, H., Sun, C., Ye, L., Xu, Y., Lin, S., Peng, Q., Wang, G., & Lu, X. (2024). Association of anti-HMGCR antibodies of the IgM isotype with refractory immune-mediated necrotizing myopathy. Arthritis Research & Therapy. https://doi.org/10.1186/s13075-024-03387-6
Vancouver
Yang H, Sun C, Ye L, Xu Y, Lin S, Peng Q, et al. Association of anti-HMGCR antibodies of the IgM isotype with refractory immune-mediated necrotizing myopathy. Arthritis Research & Therapy. 2024. doi:10.1186/s13075-024-03387-6
BibTeX
@article{Yang2024,
author = {Yang, Hongxia and Sun, Chao and Ye, Lifang and Xu, Yuetong and Lin, Sang and Peng, Qinglin and Wang, Guochun and Lu, Xin},
title = {Association of anti-HMGCR antibodies of the IgM isotype with refractory immune-mediated necrotizing myopathy},
journal = {Arthritis Research & Therapy},
year = {2024},
doi = {10.1186/s13075-024-03387-6}
}
EUVIMED